Iovance Biotherapeutics (IOVA) FCF Margin (2019 - 2026)
Iovance Biotherapeutics' FCF Margin came in at -66.71% for Q2 2026, up 58.23 percentage points from -124.95% a year earlier and up 43.47 percentage points from the prior quarter.
Iovance Biotherapeutics (IOVA) FCF Margin (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Iovance Biotherapeutics reported FCF Margin of -91.21%, up 42.75 percentage points year-over-year; for FY2025, it was -127.61%, up 94.28 percentage points from FY2024.
- Going back by year, FCF Margin was -221.88% in FY2024 (+32083.41 pp) and -32305.30% in FY2023.
- The Q2 2026 figure represents the highest quarterly FCF Margin in data going back to Q2 2023.
- Year-over-year, FCF Margin has increased for three consecutive quarters, with an average year-over-year change of +6808.29 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2024 (a gain of 43157.78 percentage points), and the weakest in Q3 2025 (a drop of 28.13 percentage points).
- Business Quant data shows IOVA's FCF Margin at -110.19% (Q1 2026), -71.32% (Q4 2025) and -132.75% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | -7.59% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7.59% |
| Jun 30, 2026 | -66.71% |
| Mar 31, 2026 | -110.19% |
| Dec 31, 2025 | -71.32% |
| Sep 30, 2025 | -132.75% |
| Jun 30, 2025 | -124.95% |
| Mar 31, 2025 | -222.82% |
| Dec 31, 2024 | -105.12% |
| Sep 30, 2024 | -104.62% |
| Jun 30, 2024 | -317.85% |
| Mar 31, 2024 | -17,685.31% |
| Dec 31, 2023 | -18,153.32% |
| Sep 30, 2023 | -18,690.83% |
| Jun 30, 2023 | -43,475.63% |
| Mar 31, 2023 | -3,025.79% |
| Dec 31, 2022 | -4,699.65% |
| Sep 30, 2022 | -8,370.14% |
| Jun 30, 2022 | -21,353.51% |
| Mar 31, 2022 | -80,416.98% |
| Dec 31, 2021 | -45,494.07% |
Iovance Biotherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();